These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26502718)

  • 1. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic tumor microenvironment in advanced retinoblastoma.
    Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
    Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
    Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL; Chu JS; Su WC; Huang SC; Lee WY
    Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia contributes to development of recurrent endometrial carcinoma.
    Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
    Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
    Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
    Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
    Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
    Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.